(Report ID: 96059) Drug interactions analysis of:
Provera, Premarin, Prempro, Medroxyprogesterone, CombipatchMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,583 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 276 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 96059 | Apr, 4, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Provera |
Premarin |
Prempro |
Medroxyprogesterone |
Combipatch |
| Name |
Breast Cancer Female |
Results from eHealthMe: 276 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Breast Cancer Female | 122 (44.20%) |
Death: 0
Cancer: 26 (100.00% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 17 (65.38%) |
2 | Breast Cancer Metastatic | 3 (11.54%) |
3 | Mastectomy | 2 (7.69%) |
4 | Pain | 2 (7.69%) |
5 | Breast Cancer Female | 2 (7.69%) |
6 | Ovarian Cancer Metastatic | 2 (7.69%) |
7 | Fibrocystic Breast Disease | 1 (3.85%) |
8 | Gastrooesophagitis | 1 (3.85%) |
9 | Fall | 1 (3.85%) |
10 | Eyelid Cyst | 1 (3.85%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Activella | 16 |
2 | Synthroid | 3 |
3 | Cycrin | 3 |
4 | Menest | 3 |
5 | Estratab | 3 |
6 | Estrace | 3 |
7 | Zoloft | 2 |
8 | Climara | 2 |
9 | Nordette-28 | 1 |
10 | Tamoxifen | 1 |
Death: 0
Cancer: 276 (100.00% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 132 (47.83%) |
2 | Breast Cancer Female | 122 (44.20%) |
3 | Pain | 22 (7.97%) |
4 | Anxiety | 20 (7.25%) |
5 | Oestrogen Receptor Assay Positive | 17 (6.16%) |
6 | Progesterone Receptor Assay Positive | 13 (4.71%) |
7 | Breast Cancer Metastatic | 12 (4.35%) |
8 | Breast Cancer In Situ | 10 (3.62%) |
9 | Depression | 9 (3.26%) |
10 | Breast Mass | 9 (3.26%) |
| Name | Count |
1 | Activella | 221 |
2 | Estrace | 112 |
3 | Climara | 106 |
4 | Cycrin | 104 |
5 | Vivelle | 92 |
6 | Aygestin | 91 |
7 | Cenestin | 91 |
8 | Estratab | 89 |
9 | Estraderm | 89 |
10 | Femhrt | 89 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
